Immunosuppression and COVID-19: Is there risk?
The first webinar in our new series gives an overview of the pandemic, digs into the risks for adults and pediatric autoimmune liver disease patients, shares more about the impact of taking immunosuppressants during infectious disease outbreaks, and answers questions from patients. The webinar is brought to you by the Autoimmune Hepatitis Association and the Center for Autoimmune Liver Disease at Cincinnati Children's Hospital.
Видео Immunosuppression and COVID-19: Is there risk? канала Autoimmune Hepatitis
Видео Immunosuppression and COVID-19: Is there risk? канала Autoimmune Hepatitis
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Nutrition and Exercise: A possible role in Autoimmune Hepatitis?COVID-19 Vaccines and Immunosuppressants: The Latest ResearchYou're the Doctor: Case Management of Liver Patients with AIH and Maybe Something ElseVitamin D and COVID 19: The Evidence for Prevention and Treatment of Coronavirus (SARS CoV 2)AARDA National Briefing on COVID-19 and Autoimmune Disease:Research Insights, Treatment & PreventionDr. Darrell DeMello Discusses COVID Outpatient ManagementLet Food Be Thy MedicineWhat IBD patients need to know about COVID-19What to Expect After Your Diagnosis of AIHCoronavirus is not the flu. It's worse.Coronavirus Is Our Future | Alanna Shaikh | TEDxSMUIs the Johnson & Johnson Vaccine Safe for AIH Patients?Living Donor Transplants: The Patient PerspectiveCOVID-19 Resources for Clinical Mental Health CounselorsAIH Boot Camp: A workshop for newly diagnosed patientsUEG Webinar recording: COVID-19 & Digestive Health #2 | End-Stage Liver Disease & TransplantationCOVID 19, Rheumatic Diseases and Immunosuppressive Drugs by Dr. Humeira BadshaQ&A With Dr. Neal Barnard!Nutrition in Autoimmune Hepatitis Dr Danielle Eagan AIHA 2017Paul Stewart, MD: Glucocorticoids and COVID-19